Meningitis from an uncommon serotype of streptococcus pneumoniae in a young child

Southern Medical Journal

Volumn 102, Issue 11, 2009, Pages 1189-

  Ahern, John W ^a,b   Raszka Jr , William V ^c  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CULTURE; CHILD; DISEASE PREDISPOSITION; HUMAN; IMMUNE SYSTEM; LETTER; MALE; MENINGITIS; NONHUMAN; PNEUMOCOCCAL INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VACCINATION;

EID: 73849095461     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181b9b137     Document Type: Letter

References (5)

1. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children. MMWR Morb Mortal Wkly Rep 2000;49:1-55.
2. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009;360: 244-256.
3. Richter SS, Heilmann KP, Dohrn CL, et al. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin Infect Dis 2009;48:e23-e33.
4. Shouval DS, Greenberg D, Givon-Lavi N, et al. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 2009;28:277-282.
5. Lynch JP III, Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009;30:189-209.